Frequency and Clinical Significance Anti-PS/PT Antibodies in Patients with Antiphospholipid Syndrome-Single Centre Observational Study in the United Kingdom.

Autor: Noble H; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom., Crossette-Thambiah C; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom., Odho Z; Department of Laboratory medicine, Royal Brompton Hospital, London, United Kingdom., Karawitage N; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom., Logan K; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom., Pericleous C; National Heart and Lung Institute, Imperial College London, London, United Kingdom., Laffan M; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom., Arachchillage DRJ; Department of Immunology and Inflammation, Centre for Haematology, Imperial College London, London, United Kingdom.; Department of Haematology, Imperial College Healthcare NHS Trust, London, United Kingdom.
Jazyk: angličtina
Zdroj: Seminars in thrombosis and hemostasis [Semin Thromb Hemost] 2023 Jul; Vol. 49 (5), pp. 553-557. Date of Electronic Publication: 2022 Nov 01.
DOI: 10.1055/s-0042-1757633
Abstrakt: Competing Interests: D.J.A. received research funding from Bayer plc and Leo Pharma (not related to this study). M.L. received consultation and speaker fees from Astra-Zeneca, Sobi, Leo-Pharma, Takeda, and Pfizer. Others have no conflict of interest to declare.
Databáze: MEDLINE